No Detail Found!

Comparative Analysis of the Levels of Matrix Metalloproteinase 9, Renal and Lipid Profile between Hypertensive and Normotensive Individuals in South Indian Population

Author(s)
Vasanthi. R Department of Biochemistry, Tirunelveli Medical College, Tirunelveli, India
Rohini.B Department of Biochemistry, Madurai medical college, Madurai, India
S. Mahalakshmi Institute of Biochemistry, Madras Medical College, Chennai, India
Kaarthikeyan Gurumoorthy Saveetha Dental College and Hospitals, Saveetha Institute of medical and technical sciences, Chennai-600077, Tamil Nadu, India
Abstract
Background/Aim: Hypertension is a prevalent chronic medical condition where the force of blood against the artery walls is high exceeding 130/80 mmHg. The vessel wall has collagen and matrix content in it. Thus the MMPs plays a role in the regulation and remodelling of the vessel wall architecture. The early stage of hypertension is regulated by MMP 9 leading to arterial stiffness and debilitation. The current research is delving into the complex interaction between MMP-9 and various inflammatory markers to uncover the fundamental mechanisms behind hypertension and discover novel avenues for more efficient treatment strategies. This study seeks to assess the levels of plasma MMP-9, serum lipid, liver and renal profile in individuals with primary hypertension, aiming to explore potential associations between these biomarkers. Methods: Fifty hypertensive individuals aged between 40 to 60 years from rural areas from south Indian population were included in this study. A control group comprised of twenty-five normotensive individuals matched for age and gender was included in the study. Under aseptic conditions, 5 ml of venous blood samples were collected in three different test tubes (EDTA, oxalate/citrate, and plain tubes), while urine samples were obtained in a fasting state. List of parameters analysed includes complete hematogram, Plasma Sugar, serumUrea and creatinine, serum Uric acid, serum Lipid profile, liver function test -LFT (SGOT, SGPT), Serum sodium, potassium, chloride, Serum MMP9 and Urinary excretion of albumin. Results: SPSS15 software has been used for Statistical analysis. There was significantly higher level of total cholesterol, TGL, LDL-C in hypertensive subjects compared to control. There was no significant change in serum HDL-C. The levels of serum MMP 9 was significantly higher in hypertensive subjects compared to controls. Urine albumin was within the normal range. Conclusion: Thus our study concludes that the MMP 9 level is elevated in hypertensive individuals and is also associated with other inflammatory markers like lipids, urea, creatinine and blood glucose levels.
Publication Details
Page(s) 11-15
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 15, Issue: 5, Year: 2026

Request the full text from PASTIC

Keywords
Health, LFT, Disease, Primary hypertension, Cardiovascular disease, MMP9
References
Lackland D.T.,Weba M.A. “ .2015 .2015 global burden of cardiovascular disease and stroke: hypertension at the core. The Canadian Journal of Cardiology, 01(2015) : 569-571.
Carretero O.A.,Oparil S. . .Essential hypertension. Part I: definition and etiology. ” Circulation, 101(2000) : 329-335.
Poulter N.R. .2015 .. Hypertension.” The Lancet, 6736(14) : 61468-9.
Halade G.V. .2013 .Matrix metalloproteinase (MMP)-9: a proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. ” Pharmacology and Therapeutics, 03 : 32-40.
Newby A.C. .2009 .Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. ” Thrombosis and Haemostasis, 101 : 1006-1011.
Williams B. . .Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society. ” Journal of Human Hypertension, 1001683(2004) : 139-185.
Meng L. . .Depression increases the risk of hypertension incidence: a meta-analysis of prospective cohort studies. ” Journal of Hypertension, 30(2012) : 842-851.
Tsounis D. . .Inflammation markers in essential hypertension. ” Medicinal Chemistry, 10(2014) : 672-681.
Turchetti V. .1999 .Evaluation of hemorheological parameters and red cell morphology in hypertension. ” Clinical Hemorheology and Microcirculation, 21 : 285-289.
Rampling M.W. .1999 .Haemorheological disturbances in hypertension: the influence of diabetes and smoking. ” Clinical Hemorheology and Microcirculation, 21 : 183-187.
Yaghoubi A. .2013 .Role of platelet parameters and haematological indices in myocardial infarction and unstable angina. ” Journal of the Pakistan Medical Association, 63 : 1133-1137.
Kumar N.L. . .Study of lipid profile, serum magnesium and blood glucose in hypertension. ” Biology and Medicine, 2(2010) : 6-16.
Saha M.S. .2006 .Serum lipid profile of hypertensive patients in the northern region of Bangladesh. ” Journal of BioScience, 14 : 93-98.
Ferretti G. .2017 .Impact of statin therapy on plasma MMP3, MMP-9, and TIMP-1 concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. ” Angiology, 68(10) : 850-862.
Raffetto J.D.,Khalil R.A. .2008 .Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular disease. ” Biochemical Pharmacology, 75 : 346-359.
Tan J. .2007 .Impact of the metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system on large arterial stiffness in patients with essential hypertension. ” Hypertension Research, 30 : 959-963.
Dollery C.M. .1995 .Matrix metalloproteases and cardiovascular disease. ” Circulation Research, 77 : 863-868.
Fang H. .2014 .Molecular mechanisms associated with angiotensin-converting enzyme-inhibitory peptide activity on vascular extracellular matrix remodeling. ” Cardiology, 127 : 247-255.
Guo Y.S. .2015 .Impact of losartan and angiotensin II on the expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat vascular smooth muscle cells. ” Molecular Medicine Reports, 11 : 1587-1594.
Ferroni P. .2003 .Serum metalloproteinase 9 levels in patients with coronary artery disease: a novel marker of inflammation. ” Journal of Investigative Medicine, 51 : 295-300.
Panimathi R. .2022 .Impact of COVID-19 on renal function: a multivariate analysis of biochemical and immunological markers in patients. ” Cureus, 14(2) : .
Vasanthii R. .2022 .Prevalence of hs-CRP among Indians with hypertension. ” Bioinformation, 18(10) : 1041.
Chitrasivasankari G. .2022 .Lipid and renal profile in assessing the severity of alcoholic liver disease. ” Bioinformation, 18(10) : 1036.
0

Citations

0

Downloads

18

Views